236 related articles for article (PubMed ID: 17428985)
1. Cysteine substitution mutants give structural insight and identify ATP binding and activation sites at P2X receptors.
Roberts JA; Evans RJ
J Neurosci; 2007 Apr; 27(15):4072-82. PubMed ID: 17428985
[TBL] [Abstract][Full Text] [Related]
2. Cysteine substitution mutagenesis and the effects of methanethiosulfonate reagents at P2X2 and P2X4 receptors support a core common mode of ATP action at P2X receptors.
Roberts JA; Digby HR; Kara M; El Ajouz S; Sutcliffe MJ; Evans RJ
J Biol Chem; 2008 Jul; 283(29):20126-36. PubMed ID: 18487206
[TBL] [Abstract][Full Text] [Related]
3. Identification of an intersubunit cross-link between substituted cysteine residues located in the putative ATP binding site of the P2X1 receptor.
Marquez-Klaka B; Rettinger J; Bhargava Y; Eisele T; Nicke A
J Neurosci; 2007 Feb; 27(6):1456-66. PubMed ID: 17287520
[TBL] [Abstract][Full Text] [Related]
4. Contribution of the region Glu181 to Val200 of the extracellular loop of the human P2X1 receptor to agonist binding and gating revealed using cysteine scanning mutagenesis.
Roberts JA; Valente M; Allsopp RC; Watt D; Evans RJ
J Neurochem; 2009 May; 109(4):1042-52. PubMed ID: 19519776
[TBL] [Abstract][Full Text] [Related]
5. Conserved cysteine residues in the extracellular loop of the human P2X(1) receptor form disulfide bonds and are involved in receptor trafficking to the cell surface.
Ennion SJ; Evans RJ
Mol Pharmacol; 2002 Feb; 61(2):303-11. PubMed ID: 11809854
[TBL] [Abstract][Full Text] [Related]
6. ATP binding at human P2X1 receptors. Contribution of aromatic and basic amino acids revealed using mutagenesis and partial agonists.
Roberts JA; Evans RJ
J Biol Chem; 2004 Mar; 279(10):9043-55. PubMed ID: 14699168
[TBL] [Abstract][Full Text] [Related]
7. Cysteine scanning mutagenesis (residues Glu52-Gly96) of the human P2X1 receptor for ATP: mapping agonist binding and channel gating.
Allsopp RC; El Ajouz S; Schmid R; Evans RJ
J Biol Chem; 2011 Aug; 286(33):29207-29217. PubMed ID: 21690089
[TBL] [Abstract][Full Text] [Related]
8. On the contribution of the first transmembrane domain to whole-cell current through an ATP-gated ionotropic P2X receptor.
Haines WR; Voigt MM; Migita K; Torres GE; Egan TM
J Neurosci; 2001 Aug; 21(16):5885-92. PubMed ID: 11487611
[TBL] [Abstract][Full Text] [Related]
9. Inter-subunit disulfide cross-linking in homomeric and heteromeric P2X receptors.
Marquez-Klaka B; Rettinger J; Nicke A
Eur Biophys J; 2009 Mar; 38(3):329-38. PubMed ID: 18427801
[TBL] [Abstract][Full Text] [Related]
10. A domain contributing to the ion channel of ATP-gated P2X2 receptors identified by the substituted cysteine accessibility method.
Egan TM; Haines WR; Voigt MM
J Neurosci; 1998 Apr; 18(7):2350-9. PubMed ID: 9502796
[TBL] [Abstract][Full Text] [Related]
11. Contribution of conserved polar glutamine, asparagine and threonine residues and glycosylation to agonist action at human P2X1 receptors for ATP.
Roberts JA; Evans RJ
J Neurochem; 2006 Feb; 96(3):843-52. PubMed ID: 16371009
[TBL] [Abstract][Full Text] [Related]
12. Mutational analysis of the conserved cysteines of the rat P2X2 purinoceptor.
Clyne JD; Wang LF; Hume RI
J Neurosci; 2002 May; 22(10):3873-80. PubMed ID: 12019306
[TBL] [Abstract][Full Text] [Related]
13. Identification of amino acid residues contributing to the pore of a P2X receptor.
Rassendren F; Buell G; Newbolt A; North RA; Surprenant A
EMBO J; 1997 Jun; 16(12):3446-54. PubMed ID: 9218787
[TBL] [Abstract][Full Text] [Related]
14. Functional and structural identification of amino acid residues of the P2X2 receptor channel critical for the voltage- and [ATP]-dependent gating.
Keceli B; Kubo Y
J Physiol; 2009 Dec; 587(Pt 24):5801-18. PubMed ID: 19884318
[TBL] [Abstract][Full Text] [Related]
15. The role of positively charged amino acids in ATP recognition by human P2X(1) receptors.
Ennion S; Hagan S; Evans RJ
J Biol Chem; 2000 Sep; 275(38):29361-7. PubMed ID: 10827197
[TBL] [Abstract][Full Text] [Related]
16. Conserved negatively charged residues are not required for ATP action at P2X(1) receptors.
Ennion SJ; Ritson J; Evans RJ
Biochem Biophys Res Commun; 2001 Dec; 289(3):700-4. PubMed ID: 11726204
[TBL] [Abstract][Full Text] [Related]
17. Interaction between cysteines introduced into each transmembrane domain of the rat P2X2 receptor.
Spelta V; Jiang LH; Bailey RJ; Surprenant A; North RA
Br J Pharmacol; 2003 Jan; 138(1):131-6. PubMed ID: 12522082
[TBL] [Abstract][Full Text] [Related]
18. Mutagenesis studies of conserved proline residues of human P2X receptors for ATP indicate that proline 272 contributes to channel function.
Roberts JA; Evans RJ
J Neurochem; 2005 Mar; 92(5):1256-64. PubMed ID: 15715674
[TBL] [Abstract][Full Text] [Related]
19. Use of chimeras, point mutants, and molecular modeling to map the antagonist-binding site of 4,4',4″,4‴-(carbonylbis-(imino-5,1,3-benzenetriylbis(carbonylimino)))tetrakisbenzene-1,3-disulfonic acid (NF449) at P2X1 receptors for ATP.
Farmer LK; Schmid R; Evans RJ
J Biol Chem; 2015 Jan; 290(3):1559-69. PubMed ID: 25425641
[TBL] [Abstract][Full Text] [Related]
20. Gain and loss of channel function by alanine substitutions in the transmembrane segments of the rat ATP-gated P2X2 receptor.
Li Z; Migita K; Samways DS; Voigt MM; Egan TM
J Neurosci; 2004 Aug; 24(33):7378-86. PubMed ID: 15317863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]